161 related articles for article (PubMed ID: 18954236)
1. Gender-based differences in treatment and outcome among HIV patients in South India.
Kumarasamy N; Venkatesh KK; Cecelia AJ; Devaleenol B; Saghayam S; Yepthomi T; Balakrishnan P; Flanigan T; Solomon S; Mayer KH
J Womens Health (Larchmt); 2008 Nov; 17(9):1471-5. PubMed ID: 18954236
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India.
Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Yephthomi T; Pradeep A; Saghayam S; Flanigan T; Mayer KH; Solomon S
Int J Infect Dis; 2010 Feb; 14(2):e127-31. PubMed ID: 19632872
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes among HIV/tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India.
Kumarasamy N; Venkatesh KK; Vignesh R; Devaleenal B; Poongulali S; Yepthomi T; Flanigan TP; Benson C; Mayer KH
J Int Assoc Provid AIDS Care; 2013; 12(1):28-31. PubMed ID: 23011868
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.
Arici C; Ripamonti D; Ravasio V; Maggiolo F; Rizzi M; Finazzi MG; Suter F
Int J STD AIDS; 2001 Sep; 12(9):573-81. PubMed ID: 11516366
[TBL] [Abstract][Full Text] [Related]
5. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India.
Sundaram M; Saghayam S; Priya B; Venkatesh KK; Balakrishnan P; Shankar EM; Murugavel KG; Solomon S; Kumarasamy N
Int J Infect Dis; 2008 Nov; 12(6):e61-6. PubMed ID: 18621564
[TBL] [Abstract][Full Text] [Related]
6. Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.
Ogoina D; Adekunle V; Obiako R; Umar A; Akolawole M; Ovosi J
Pan Afr Med J; 2011; 9():38. PubMed ID: 22355437
[TBL] [Abstract][Full Text] [Related]
7. Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital.
Mzileni MO; Longo-Mbenza B; Chephe TJ
Pol Arch Med Wewn; 2008 Oct; 118(10):548-54. PubMed ID: 19112815
[TBL] [Abstract][Full Text] [Related]
8. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
Kumarasamy N; Venkatesh KK; Cecelia AJ; Devaleenal B; Lai AR; Saghayam S; Balakrishnan P; Yepthomi T; Poongulali S; Flanigan TP; Solomon S; Mayer KH
AIDS Patient Care STDS; 2008 Apr; 22(4):337-44. PubMed ID: 18422462
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
12. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
[TBL] [Abstract][Full Text] [Related]
13. Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India.
Kumarasamy N; Vallabhaneni S; Cecelia AJ; Yepthomi T; Balakrishnan P; Saghayam S; Flanigan TP; Carpenter CC; Solomon S; Mayer KH
J Acquir Immune Defic Syndr; 2006 Jan; 41(1):53-8. PubMed ID: 16340473
[TBL] [Abstract][Full Text] [Related]
14. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
[TBL] [Abstract][Full Text] [Related]
15. Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda.
Baalwa J; Mayanja-Kizza H; Kamya MR; John L; Kambugu A; Colebunders R
Afr Health Sci; 2008 Sep; 8(3):190-5. PubMed ID: 19357749
[TBL] [Abstract][Full Text] [Related]
16. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and frequency of tuberculosis-associated immune reconstitution inflammatory syndrome among HIV/Tuberculosis co-infected patients in Southern India.
Vignesh R; Swathirajan CR; Solomon SS; Shankar EM; Murugavel KG
Indian J Med Microbiol; 2017; 35(2):279-281. PubMed ID: 28681821
[TBL] [Abstract][Full Text] [Related]
18. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
[TBL] [Abstract][Full Text] [Related]
19. Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Johansen IS; Katzenstein TL; Pedersen G; Storgaard M; Obel N; Lebech AM
BMC Infect Dis; 2012 Nov; 12():293. PubMed ID: 23140254
[TBL] [Abstract][Full Text] [Related]
20. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.
Li X; Ding H; Geng W; Liu J; Jiang Y; Xu J; Zhang Z; Shang H
BMC Infect Dis; 2019 May; 19(1):373. PubMed ID: 31046702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
